So this is mainly a long-awaited response to BioMed Central and its subsequent acquisition by Springer (http://www.biomedcentral.com) and others like it (there are a few) using the Open Access model prototyped by Gene Garfield, Vitek Tracz and others, surely. Nothing new, merely late bandwagon-jumping, surely.
Slashdot Mirror
So this is mainly a long-awaited response to BioMed Central and its subsequent acquisition by Springer (http://www.biomedcentral.com) and others like it (there are a few) using the Open Access model prototyped by Gene Garfield, Vitek Tracz and others, surely. Nothing new, merely late bandwagon-jumping, surely.